Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.37 |
| ▸ | RRM1 | P23921 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8989023 | 1.00 | CCR6 (0.41) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL667448 | 0.98 | CCR6 (0.42) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL7305614 | 0.94 | LTA4H (0.41) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL8495462 | 0.87 | CCR6 (0.38) | CCR6PAX8L3MBTL1LTA4HEPHX2 | |
| SCHEMBL9879981 | 0.85 | MAPT (0.49) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL6618522 | 0.85 | MAPT (0.49) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL12487961 | 0.85 | L3MBTL1 (0.38) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL12487405 | 0.85 | L3MBTL1 (0.38) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL8988866 | 0.85 | L3MBTL1 (0.37) | CCR6PAX8L3MBTL1HDAC2HDAC8 | |
| SCHEMBL8989038 | 0.85 | L3MBTL1 (0.37) | CCR6PAX8L3MBTL1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8961931-B2 | 18F-labeled monomeric galactose derivative used as tomography probe | INSTITUTE OF NUCLEAR ENERGY RESEARCH, ATOMIC ENERGY COUNCIL (TW) | 2015-02-24 | — | — | US | disclosed |
| US-20120259102-A1 | 18F-Labeled Monomeric Galactose Derivative Used as Tomography Probe | ATOMIC ENERGY COUNCIL-INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2012-10-11 | — | — | US | disclosed |
| US-6406894-B1 | BIODEGRADABLE POLYMER, DISACCHARIDE OR OLIGOSACCHARIDE, CROSSLINKING AND COUPLING | GLYCOREX AB (SE) | 2002-06-18 | — | — | US | disclosed |
| US-5488140-A | ANTICONVULSANTS | CIBA-GEIGY CORPORATION (US) | 1996-01-30 | — | — | US | disclosed |
| EP-0420806-B1 | Phosphonic acids, process for preparation and use as an active pharmaceutical composition | CIBA GEIGY AG (CH) | 1995-07-05 | — | — | EP | disclosed |
| US-5294734-A | 1-phosphato-4-amino-pent-2-enoic acids and derivatives | CIBA-GEIGY CORP. (US) | 1994-03-15 | — | — | US | disclosed |
| EP-0420806-A1 | Phosphonic acids, process for preparation and use as an active pharmaceutical composition | CIBA-GEIGY AG (CH) | 1991-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120259102-A1 | 18F-Labeled Monomeric Galactose Derivative Used as Tomography Probe | UGGT1, GALK1, GALE | CCR6 4589/4885PAX8 3255/4885L3MBTL1 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.